[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-448729-105":59,"doc-detail-448729-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","572-ethnic-inequalities-in-preventive-care-for-cardiovascular-disease-in-australia-abstract","572 Ethnic inequalities in preventive care for cardiovascular disease in Australia - Abstract","","International evidence indicates that primary prevention for cardiovascular disease (CVD) varies by ethnicity. Australian studies have shown undertreatment of CVD risk factors among Aboriginal and Torres Strait Islander Australians, yet similar inequalities in preventive therapies for non-Indigenous populations remain unclear. This study examines differences in primary preventative drug therapy for CVD by ethnicity in Australia using a Census-linked New South Wales cohort.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/572-ethnic-inequalities-in-preventive-care-for-cardiovascular-disease-in-australia-abstract/448729/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/572-ethnic-inequalities-in-preventive-care-for-cardiovascular-disease-in-australia-abstract/448729.png","ImageObject",300,407,{"name":92,"@type":93},"Damian","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-05","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main aim?","Question",{"text":112,"@type":113},"To determine whether inequalities exist in primary preventative drug therapy for cardiovascular disease by ethnicity in Australia.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the data collected and analyzed?",{"text":117,"@type":113},"The study used a Census-linked cohort of NSW residents aged 30+ without prior CVD, identifying incident events through hospitalisation or death records (ICD-10-AM) and assessing preventive drug use in the two years before the first event via linked prescription data.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about differences across groups?",{"text":121,"@type":113},"Overall uptake of preventive drug therapy was high, but lower proportions were observed for Asian males, Pasifika males, and Māori females before their first CVD event compared with the population average.",{"name":123,"@type":110,"acceptedAnswer":124},"What are the study’s conclusions for preventive care?",{"text":125,"@type":113},"Access to preventive medication for CVD in Australia differs by ethnicity and sex, with lower prescribing in males and in Māori groups noted as concerning given higher CVD incidence.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},448729,1790768213,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":14,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":24},137451208677,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","2nd World Congress on Migration, Ethnicity, Race & Health Abstract Book vi67  \nAbstract citation ID: ckaf180.185  \n572 Ethnic inequalities in preventive care for  \ncardiovascular disease in Australia  \nYiyi Lin1, Lin Zhu1, Peiyao Xu1, Leonard Kritharides2, Saman KhalatbariSoltani1, Benjumin Hsu3, Sarah Aitken1, Andrew Wilson1, Carmen Huckel Schneider1, Louisa Jorm4, Michelle Dickson1, Fiona Stanaway1 1Faculty of Medicine and Health, Sydney School of Public Health, Sydney, Australia 2Concord General Hospital, Sydney Local Health District, Sydney, Australia 3Marcus Institute for Aging Research, Harvard Medical School, Boston,  \nUnited States  \n4Centre for Big Data Research in Health, UNSW Sydney, Sydney, Australia  \nOP 29: Health Status 4, B302 (FCSH), September 4, 2025, 16:00  \n- 17:00  \nAim: International evidence has found that receipt of primary prevention for cardiovascular disease (CVD) can differ by ethnicity. Prior Australian research has demonstrated undertreatment of CVD risk factors in Aboriginal and Torres Strait Islander Australians. However, inequalities in the receipt of preventive therapies have not been examined in Australia’s non-Indigenous population. The aim of this study is to determine the presence of inequalities in primary preventative drug therapy for CVD by ethnicity in Australia.  \nMethods: We used data from a Census-linked cohort study of the New South Wales population aged 30 years and over. We created a  \nvi68 European Journal of Public Health, Vol. 35, Supplement 6, 2025  \ncohort of individuals without prior history of a CVD event, who experienced their first CVD event during the period August 9, 2016 to June 2022 . Incident CVD events were identified from hospitalisation or death records using relevant ICD-10-AM codes. We examined use of any preventative drug therapy (blood pressure and lipid lowering medications) in the two years prior to the first CVD event using linked prescription record data.  \nResults: In preliminary analyses, we found that the proportion of individuals receiving at least one prescription of preventative drug therapy was overall high in the cohort (0.88, 95%CI [0.87, 0.88]) . A higher proportion of females (0.89, 95%CI [0.89, 0.89]) were prescribed preventive therapy compared to males (0.86, 95%CI [0.86, 0.87]) . In addition, we found a lower proportion of Asian males (0.81, 95%CI [0.78, 0.84]), Pasifika males (0.72, 95%CI [0.63, 0.82]) and M 􀀁aori females (0.69, 95%CI [0.52, 0.86]) were prescribed preventive medication before their first CVD event compared to the population average.  \nConclusion: These fundings suggest that access to preventive medication for CVD in Australia differs by ethnicity and sex. Lower prescriptions in males and in Mare concerning given their higher incidence of CVD.","cbCaiaHg2xjTGPYM","https://ap.wps.com/l/cbCaiaHg2xjTGPYM","pdf",67655,"English","# Aim\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the study’s main aim?\",\"answer\":\"To determine whether inequalities exist in primary preventative drug therapy for cardiovascular disease by ethnicity in Australia.\"},{\"question\":\"How was the data collected and analyzed?\",\"answer\":\"The study used a Census-linked cohort of NSW residents aged 30+ without prior CVD, identifying incident events through hospitalisation or death records (ICD-10-AM) and assessing preventive drug use in the two years before the first event via linked prescription data.\"},{\"question\":\"What did the results show about differences across groups?\",\"answer\":\"Overall uptake of preventive drug therapy was high, but lower proportions were observed for Asian males, Pasifika males, and Māori females before their first CVD event compared with the population average.\"},{\"question\":\"What are the study’s conclusions for preventive care?\",\"answer\":\"Access to preventive medication for CVD in Australia differs by ethnicity and sex, with lower prescribing in males and in Māori groups noted as concerning given higher CVD incidence.\"}]","572 Ethnic inequalities in preventive care for cardiovascular disease in Australia - Abstract | PDF",1790728608]